MITEM subst sèche 20 mg intravésical set
7680632370028
CH-63237
L01DC03
07.16.1.
Reimbursement limitations:
MITEM
Utilisation pour la prévention des récidives de carcinomes vésicaux superficiels après résection transurétrale.
1 / 3
google
Details
- Product number
- 6323701
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- Praeparatio sicca: mitomycinum 20 mg, mannitolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, pro vitro.
Articles (1)
Mitem 20 mg, poudre pour solution injectable ou pour perfusion
poudre pour solution injectable ou pour perfusion
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 124.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2015
Authorization holder
Leman SKL SA
1213 Lancy
Authorization information
- Swissmedic authorization number
- 63237
- Drug name
- Mitem 20 mg, poudre pour solution injectable ou pour perfusion
- Galenic form
- PULVII
- ATC Code
- L01DC03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/12/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MITEM subst sèche 20 mg intravésical set
- Description (DE)
- MITEM Trockensub 20 mg intravesikal Set
- Market launch
- 17/12/2014
- Narcotic (BTM)
- No